vs

Side-by-side financial comparison of Coterra (CTRA) and ILLUMINA, INC. (ILMN). Click either name above to swap in a different company.

Coterra is the larger business by last-quarter revenue ($1.8B vs $1.1B, roughly 1.6× ILLUMINA, INC.). Coterra runs the higher net margin — 20.6% vs 12.3%, a 8.3% gap on every dollar of revenue. On growth, Coterra posted the faster year-over-year revenue change (23.8% vs 4.8%). Over the past eight quarters, Coterra's revenue compounded faster (11.8% CAGR vs -1.3%).

Coterra Energy Inc. is an American energy company engaged in hydrocarbon exploration based in Houston, Texas. The company has operations in the Permian Basin, Marcellus Shale, and the Anadarko Basin.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

CTRA vs ILMN — Head-to-Head

Bigger by revenue
CTRA
CTRA
1.6× larger
CTRA
$1.8B
$1.1B
ILMN
Growing faster (revenue YoY)
CTRA
CTRA
+19.0% gap
CTRA
23.8%
4.8%
ILMN
Higher net margin
CTRA
CTRA
8.3% more per $
CTRA
20.6%
12.3%
ILMN
Faster 2-yr revenue CAGR
CTRA
CTRA
Annualised
CTRA
11.8%
-1.3%
ILMN

Income Statement — Q4 FY2025 vs Q1 FY2027

Metric
CTRA
CTRA
ILMN
ILMN
Revenue
$1.8B
$1.1B
Net Profit
$368.0M
$134.0M
Gross Margin
66.1%
Operating Margin
31.9%
19.2%
Net Margin
20.6%
12.3%
Revenue YoY
23.8%
4.8%
Net Profit YoY
23.9%
EPS (diluted)
$0.47
$0.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRA
CTRA
ILMN
ILMN
Q1 26
$1.1B
Q4 25
$1.8B
$1.2B
Q3 25
$1.8B
Q2 25
$1.7B
Q1 25
$2.0B
Q4 24
$1.4B
$1.1B
Q3 24
$1.3B
$1.1B
Q2 24
$1.3B
$1.1B
Net Profit
CTRA
CTRA
ILMN
ILMN
Q1 26
$134.0M
Q4 25
$368.0M
$334.0M
Q3 25
$322.0M
Q2 25
$511.0M
Q1 25
$516.0M
Q4 24
$297.0M
$186.0M
Q3 24
$252.0M
$705.0M
Q2 24
$220.0M
$-2.0B
Gross Margin
CTRA
CTRA
ILMN
ILMN
Q1 26
66.1%
Q4 25
65.5%
Q3 25
Q2 25
Q1 25
Q4 24
65.9%
Q3 24
69.0%
Q2 24
64.8%
Operating Margin
CTRA
CTRA
ILMN
ILMN
Q1 26
19.2%
Q4 25
31.9%
17.4%
Q3 25
26.8%
Q2 25
40.9%
Q1 25
34.8%
Q4 24
22.5%
15.8%
Q3 24
25.3%
68.6%
Q2 24
23.0%
-147.2%
Net Margin
CTRA
CTRA
ILMN
ILMN
Q1 26
12.3%
Q4 25
20.6%
28.8%
Q3 25
18.3%
Q2 25
29.5%
Q1 25
25.6%
Q4 24
20.5%
16.8%
Q3 24
19.5%
65.3%
Q2 24
17.1%
-178.8%
EPS (diluted)
CTRA
CTRA
ILMN
ILMN
Q1 26
$0.87
Q4 25
$0.47
$2.16
Q3 25
$0.42
Q2 25
$0.67
Q1 25
$0.68
Q4 24
$0.40
$1.16
Q3 24
$0.34
$4.42
Q2 24
$0.29
$-12.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRA
CTRA
ILMN
ILMN
Cash + ST InvestmentsLiquidity on hand
$114.0M
$1.2B
Total DebtLower is stronger
$3.8B
Stockholders' EquityBook value
$14.8B
$2.7B
Total Assets
$24.2B
$6.6B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRA
CTRA
ILMN
ILMN
Q1 26
$1.2B
Q4 25
$114.0M
$1.6B
Q3 25
$98.0M
Q2 25
$192.0M
Q1 25
$186.0M
Q4 24
$2.0B
$93.0M
Q3 24
$843.0M
$70.0M
Q2 24
$1.3B
$74.0M
Total Debt
CTRA
CTRA
ILMN
ILMN
Q1 26
Q4 25
$3.8B
Q3 25
$3.9B
Q2 25
$4.2B
Q1 25
$4.3B
Q4 24
$3.5B
Q3 24
$2.1B
Q2 24
$2.6B
Stockholders' Equity
CTRA
CTRA
ILMN
ILMN
Q1 26
$2.7B
Q4 25
$14.8B
$2.7B
Q3 25
$14.7B
Q2 25
$14.6B
Q1 25
$14.2B
Q4 24
$13.1B
$2.4B
Q3 24
$13.0B
$2.1B
Q2 24
$13.0B
$1.4B
Total Assets
CTRA
CTRA
ILMN
ILMN
Q1 26
$6.6B
Q4 25
$24.2B
$6.6B
Q3 25
$24.0B
Q2 25
$24.0B
Q1 25
$24.0B
Q4 24
$21.6B
$6.3B
Q3 24
$20.1B
$6.0B
Q2 24
$20.8B
$6.1B
Debt / Equity
CTRA
CTRA
ILMN
ILMN
Q1 26
Q4 25
0.26×
Q3 25
0.27×
Q2 25
0.29×
Q1 25
0.30×
Q4 24
0.27×
Q3 24
0.16×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRA
CTRA
ILMN
ILMN
Operating Cash FlowLast quarter
$970.0M
$289.0M
Free Cash FlowOCF − Capex
$251.0M
FCF MarginFCF / Revenue
23.0%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.64×
2.16×
TTM Free Cash FlowTrailing 4 quarters
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRA
CTRA
ILMN
ILMN
Q1 26
$289.0M
Q4 25
$970.0M
$321.0M
Q3 25
$971.0M
Q2 25
$936.0M
Q1 25
$1.1B
Q4 24
$626.0M
$364.0M
Q3 24
$755.0M
$316.0M
Q2 24
$558.0M
$80.0M
Free Cash Flow
CTRA
CTRA
ILMN
ILMN
Q1 26
$251.0M
Q4 25
$267.0M
Q3 25
Q2 25
Q1 25
Q4 24
$335.0M
Q3 24
$284.0M
Q2 24
$49.0M
FCF Margin
CTRA
CTRA
ILMN
ILMN
Q1 26
23.0%
Q4 25
23.0%
Q3 25
Q2 25
Q1 25
Q4 24
30.3%
Q3 24
26.3%
Q2 24
4.4%
Capex Intensity
CTRA
CTRA
ILMN
ILMN
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
2.6%
Q3 24
3.0%
Q2 24
2.8%
Cash Conversion
CTRA
CTRA
ILMN
ILMN
Q1 26
2.16×
Q4 25
2.64×
0.96×
Q3 25
3.02×
Q2 25
1.83×
Q1 25
2.22×
Q4 24
2.11×
1.96×
Q3 24
3.00×
0.45×
Q2 24
2.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTRA
CTRA

Oil And Condensate$941.0M53%
Natural Gas Production$615.0M34%
Natural Gas Liquids Reserves$206.0M12%
Other Revenues$28.0M2%

ILMN
ILMN

Product revenue$917.0M84%
Service and other revenue$174.0M16%

Related Comparisons